Repare Therapeutics
RPTX
RPTX was delisted on the 27th of January, 2026.
66 hedge funds and large institutions have $708M invested in Repare Therapeutics in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 6 closing their positions.
208% more call options, than puts
Call options by funds: $1.93M | Put options by funds: $627K
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
8% more funds holding
Funds holding: 61 → 66 (+5)
0.89% more ownership
Funds ownership: 71.73% → 72.63% (+0.89%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
15% less capital invested
Capital invested by funds: $828M → $708M (-$121M)
17% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$30.4M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$23.9M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$6.79M |
| 4 |
Millennium Management
New York
|
+$4.81M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$3.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$11.3M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$11.1M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
-$10M |
| 4 |
CA
CHI Advisors
New York
|
-$9.91M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.87M |
RPTX Hedge Fund Activity: Q3 2021 in Review
66 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q3 2021, worth a combined $708M — down 15% from $828M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new RPTX positions and 6 closed out — a net gain of 7 holders — while 19 added to existing stakes and 23 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $30.4M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $11.3M sold.
- 66 institutional investors held Repare Therapeutics (RPTX) as of Q3 2021, up from 61 in Q2 2021.
- Funds reported $708M of Repare Therapeutics stock for Q3 2021, down 15% quarter-over-quarter.
- 13 funds opened new Repare Therapeutics positions in Q3 2021 and 6 closed out, a net change of +7 holders.
- The largest Repare Therapeutics buyer in Q3 2021 was ARK Investment Management, an estimated $30.4M added.
- The largest Repare Therapeutics seller in Q3 2021 was Cormorant Asset Management, an estimated $11.3M sold.
Based on aggregated 13F filings for Q3 2021.